Decreased Spinal Fluid Monoamine Metabolites and Norepinephrine in Schizophrenic Patients with Brain Atrophy
- 1 January 1985
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Ventricular enlargement in schizophrenia: relationship to positive and negative symptomsAmerican Journal of Psychiatry, 1982
- Cerebral Glucography With Positron TomographyArchives of General Psychiatry, 1982
- Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophreniaNeuroscience Letters, 1980
- Cerebral Ventricular Size and Neuropsychological Impairment in Young Chronic SchizophrenicsArchives of General Psychiatry, 1980
- CSF monoamine metabolites in depression and schizophreniaAmerican Journal of Psychiatry, 1980
- CHARACTERISTICS OF PATIENTS WITH SCHIZOPHRENIA OR NEUROLOGICAL DISORDER AND VIRUS-LIKE AGENT IN CEREBROSPINAL FLUIDThe Lancet, 1979
- CEREBRAL VENTRICULAR SIZE AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIAPublished by Elsevier ,1976
- Brain hypoxia, minimal brain dysfunction, and schizophreniaAmerican Journal of Psychiatry, 1975
- ABNORMALITIES OF CEREBRAL BLOOD FLOW DISTRIBUTION IN PATIENTS WITH CHRONIC SCHIZOPHRENIAActa Psychiatrica Scandinavica, 1974
- 5-Hydroxyindoleacetic acid (5 HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazinesPsychopharmacology, 1973